Abstract
Betel quid (BQ) is a widely accepted etiological factor for oral squamous cell carcinoma (OSCC) in Southeast Asia, but how BQ chewing leads to oral carcinogenesis remains to be elucidated. We have previously demonstrated that the activation of Src family kinases (SFKs) is critical for BQ-induced oral cancer cell motility. Here we investigate whether this biological effect is mediated by specific membrane receptors in oral cancer cells. We found that BQ-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and cell migration could be inhibited by atropine, suggesting the involvement of the muscarinic receptor family. The enhanced activities of ERK1/2 and cell migration were significantly counteracted by PD102807, the selective antagonist of muscarinic M4 receptor. Moreover, cold BQ extract effectively competed with a known ligand, [(3)H]-N-methyl scopolamine, for binding to muscarinic M4 receptor in vitro, thereby implying that BQ could activate motility-promoting signaling pathways through direct interaction with the receptor. The requirement of muscarinic M4 receptor for BQ-induced oral cancer cell migration was demonstrated by knockdown of the receptor using RNA interference (RNAi). Remarkably, ectopic expr...Continue Reading
References
Dec 1, 1991·International Journal of Epidemiology·S Y Choi, H Kahyo
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J S GutkindK C Robbins
Aug 15, 1993·Cancer·A MashbergL Garfinkel
Nov 18, 2000·The Journal of Biological Chemistry·D C BuddA B Tobin
Jul 12, 2003·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Wen-Liang LoRichard Che-Shoa Chang
Aug 2, 2003·Receptors & Channels·A A LanzafameF Mitchelson
May 25, 2004·International Journal of Epidemiology·Gwenn MenvielleAnnette Leclerc
Jul 21, 2004·The Journal of Cell Biology·Alex I ChernyavskySergei A Grando
Sep 1, 2005·Journal of Biomolecular Screening·Ronald I W OsmondAnthony R Dyer
Sep 1, 2005·Journal of Biomedical Science·Hsinyo Chen
Jan 28, 2006·Neurochemistry International·Qiao-Ling CuiGuillermina Almazan
Aug 2, 2006·Autonomic & Autacoid Pharmacology·R M Eglen
Dec 16, 2006·The EMBO Journal·Yutong SunXin-Yun Huang
Dec 19, 2006·Oral Oncology·Chun-Ta LiaoTzu-Chen Yen
Apr 19, 2007·Cancer Research·Pingfang SongEliot R Spindel
Nov 15, 2007·Molecular BioSystems·Yutong SunXin-Yun Huang
Jan 1, 2008·Annals of Surgical Oncology·Chun-Ta LiaoTzu-Chen Yen
Jun 19, 2008·Cancer Research·Pingfang SongEliot R Spindel
Aug 30, 2008·Cancer Science·Yin-Ju ChenAnn-Joy Cheng
Feb 14, 2009·Oral Oncology·Mei-Yu TsengJeff Yi-Fu Chen
Mar 3, 2009·Cellular Signalling·Mathieu Cotton, Audrey Claing
Dec 24, 2009·Current Pharmaceutical Design·Irina G Tikhonova, Stefano Costanzi
Citations
Sep 26, 2012·Journal of Clinical Immunology·Laura T PelegrinaMaría E Sales
Jan 15, 2013·Journal of Pharmaceutical and Biomedical Analysis·Chun-Liang TungHong-Lin Chan
Feb 15, 2011·Oral Oncology·Yi-Ting DengMark Yen-Ping Kuo
Nov 21, 2012·Oral Diseases·S-J ChengC-P Chiang
Feb 18, 2014·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Wan-Chun LiKuo-Wei Chang
Feb 5, 2013·Oral Oncology·Wei-Fan ChiangJeff Yi-Fu Chen
Apr 28, 2016·International Journal of Molecular Sciences·San-Yuan ChenYing-Ray Lee
Feb 27, 2016·Oncotarget·Mei-Chi ChangJiiang-Huei Jeng
Feb 18, 2015·Oncotarget·Chih-Chang HungJeff Yi-Fu Chen
Mar 22, 2019·Cancers·Yao-Kuang WangI-Chen Wu
Feb 6, 2017·PloS One·Chia-Hsuan ChouChiao-Wen Lin
Oct 31, 2020·Cancers·Anna Maria Lucianò, Ada Maria Tata
Jul 1, 2021·World Journal of Clinical Oncology·Alejandro EspañolMaría Elena Sales